1. Targeting cullin-RING ligases for cancer treatment: rationales, advances and therapeutic implications
   Shuju Wu et al, 2016, Cytotechnology CrossRef
2. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
   Kristina Bielskienė et al, 2015, Medicina CrossRef
3. TAS4464, A Highly Potent and Selective Inhibitor of NEDD8-Activating Enzyme, Suppresses Neddylation and Shows Antitumor Activity in Diverse Cancer Models
   Chihoko Yoshimura et al, 2019, Molecular Cancer Therapeutics CrossRef
4. Integrated analysis reveals the regulatory mechanism of the neddylation inhibitor MLN4924 on the metabolic dysregulation in rabbit granulosa cells
   Mengjuan Chen et al, 2024, BMC Genomics CrossRef
5. Structural basis for Cullins and RING component inhibition: Targeting E3 ubiquitin pathway conductors for cancer therapeutics
   Shagufta Shafique et al, 2018, International Journal of Biological Macromolecules CrossRef
6. UCHL3 plays an important role in the occurrence and development of melanoma
   Runzhi He et al, 2021, Oncology Letters CrossRef